3.25.4 html 115 260 1 false 45 0 false 7 false false R1.htm 995200090 - Document - Document And Entity Information Sheet http://www.outlooktherapeutics.com/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 995200100 - Statement - Consolidated Balance Sheets Sheet http://www.outlooktherapeutics.com/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 995200105 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.outlooktherapeutics.com/role/StatementConsolidatedBalanceSheetsParentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 995200200 - Statement - Consolidated Statements of Operations Sheet http://www.outlooktherapeutics.com/role/StatementConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 995200300 - Statement - Consolidated Statements of Stockholders' Deficit Sheet http://www.outlooktherapeutics.com/role/StatementConsolidatedStatementsOfStockholdersDeficit Consolidated Statements of Stockholders' Deficit Statements 5 false false R6.htm 995200400 - Statement - Consolidated Statements of Cash Flows Sheet http://www.outlooktherapeutics.com/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 995210101 - Disclosure - Organization and Description of Business Sheet http://www.outlooktherapeutics.com/role/DisclosureOrganizationAndDescriptionOfBusiness Organization and Description of Business Notes 7 false false R8.htm 995210201 - Disclosure - Liquidity Sheet http://www.outlooktherapeutics.com/role/DisclosureLiquidity Liquidity Notes 8 false false R9.htm 995210301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies Notes 9 false false R10.htm 995210401 - Disclosure - Fair Value Measurements Sheet http://www.outlooktherapeutics.com/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 10 false false R11.htm 995210501 - Disclosure - Equity Method Investment Sheet http://www.outlooktherapeutics.com/role/DisclosureEquityMethodInvestment Equity Method Investment Notes 11 false false R12.htm 995210601 - Disclosure - Accrued Expenses Sheet http://www.outlooktherapeutics.com/role/DisclosureAccruedExpenses Accrued Expenses Notes 12 false false R13.htm 995210701 - Disclosure - Debt Sheet http://www.outlooktherapeutics.com/role/DisclosureDebt Debt Notes 13 false false R14.htm 995210801 - Disclosure - Commitments and Contingencies Sheet http://www.outlooktherapeutics.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 14 false false R15.htm 995210901 - Disclosure - Common Stock and Stockholders' Equity Sheet http://www.outlooktherapeutics.com/role/DisclosureCommonStockAndStockholdersEquity Common Stock and Stockholders' Equity Notes 15 false false R16.htm 995211001 - Disclosure - Stock-Based Compensation Sheet http://www.outlooktherapeutics.com/role/DisclosureStockBasedCompensation Stock-Based Compensation Notes 16 false false R17.htm 995211101 - Disclosure - Segment Information Sheet http://www.outlooktherapeutics.com/role/DisclosureSegmentInformation Segment Information Notes 17 false false R18.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 18 false false R19.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 19 false false R20.htm 99920302 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies 20 false false R21.htm 99930303 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables Basis of Presentation and Summary of Significant Accounting Policies (Tables) Tables http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies 21 false false R22.htm 99930403 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.outlooktherapeutics.com/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.outlooktherapeutics.com/role/DisclosureFairValueMeasurements 22 false false R23.htm 99930603 - Disclosure - Accrued Expenses (Tables) Sheet http://www.outlooktherapeutics.com/role/DisclosureAccruedExpensesTables Accrued Expenses (Tables) Tables http://www.outlooktherapeutics.com/role/DisclosureAccruedExpenses 23 false false R24.htm 99930703 - Disclosure - Debt (Tables) Sheet http://www.outlooktherapeutics.com/role/DisclosureDebtTables Debt (Tables) Tables http://www.outlooktherapeutics.com/role/DisclosureDebt 24 false false R25.htm 99930803 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.outlooktherapeutics.com/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.outlooktherapeutics.com/role/DisclosureCommitmentsAndContingencies 25 false false R26.htm 99930903 - Disclosure - Common Stock and Stockholders' Equity (Tables) Sheet http://www.outlooktherapeutics.com/role/DisclosureCommonStockAndStockholdersEquityTables Common Stock and Stockholders' Equity (Tables) Tables http://www.outlooktherapeutics.com/role/DisclosureCommonStockAndStockholdersEquity 26 false false R27.htm 99931003 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.outlooktherapeutics.com/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.outlooktherapeutics.com/role/DisclosureStockBasedCompensation 27 false false R28.htm 99931103 - Disclosure - Segment Information (Tables) Sheet http://www.outlooktherapeutics.com/role/DisclosureSegmentInformationTables Segment Information (Tables) Tables http://www.outlooktherapeutics.com/role/DisclosureSegmentInformation 28 false false R29.htm 99940201 - Disclosure - Liquidity (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureLiquidityDetails Liquidity (Details) Details http://www.outlooktherapeutics.com/role/DisclosureLiquidity 29 false false R30.htm 99940301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounts Receivable (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAccountsReceivableDetails Basis of Presentation and Summary of Significant Accounting Policies - Accounts Receivable (Details) Details 30 false false R31.htm 99940302 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Inventory (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesInventoryDetails Basis of Presentation and Summary of Significant Accounting Policies - Inventory (Details) Details http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 31 false false R32.htm 99940303 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue recognition (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails Basis of Presentation and Summary of Significant Accounting Policies - Revenue recognition (Details) Details 32 false false R33.htm 99940304 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - EPS (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEpsDetails Basis of Presentation and Summary of Significant Accounting Policies - EPS (Details) Details http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 33 false false R34.htm 99940305 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Dilutive securities (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDilutiveSecuritiesDetails Basis of Presentation and Summary of Significant Accounting Policies - Dilutive securities (Details) Details 34 false false R35.htm 99940401 - Disclosure - Fair Value Measurements (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureFairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.outlooktherapeutics.com/role/DisclosureFairValueMeasurementsTables 35 false false R36.htm 99940402 - Disclosure - Fair Value Measurements - Fair value changes (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureFairValueMeasurementsFairValueChangesDetails Fair Value Measurements - Fair value changes (Details) Details 36 false false R37.htm 99940403 - Disclosure - Fair Value Measurements - Assumptions (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureFairValueMeasurementsAssumptionsDetails Fair Value Measurements - Assumptions (Details) Details 37 false false R38.htm 99940404 - Disclosure - Fair Value Measurements - Common stock warrants (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureFairValueMeasurementsCommonStockWarrantsDetails Fair Value Measurements - Common stock warrants (Details) Details 38 false false R39.htm 99940501 - Disclosure - Equity Method Investment - Syntone (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureEquityMethodInvestmentSyntoneDetails Equity Method Investment - Syntone (Details) Details 39 false false R40.htm 99940601 - Disclosure - Accrued Expenses (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureAccruedExpensesDetails Accrued Expenses (Details) Details http://www.outlooktherapeutics.com/role/DisclosureAccruedExpensesTables 40 false false R41.htm 99940701 - Disclosure - Debt - Summary (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureDebtSummaryDetails Debt - Summary (Details) Details 41 false false R42.htm 99940702 - Disclosure - Debt - Information (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureDebtInformationDetails Debt - Information (Details) Details 42 false false R43.htm 99940801 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureCommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.outlooktherapeutics.com/role/DisclosureCommitmentsAndContingenciesTables 43 false false R44.htm 99940802 - Disclosure - Commitments and Contingencies - Lease cost (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureCommitmentsAndContingenciesLeaseCostDetails Commitments and Contingencies - Lease cost (Details) Details 44 false false R45.htm 99940803 - Disclosure - Commitments and Contingencies - Lease balance sheet (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureCommitmentsAndContingenciesLeaseBalanceSheetDetails Commitments and Contingencies - Lease balance sheet (Details) Details 45 false false R46.htm 99940804 - Disclosure - Commitments and Contingencies - Lease cash flow (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureCommitmentsAndContingenciesLeaseCashFlowDetails Commitments and Contingencies - Lease cash flow (Details) Details 46 false false R47.htm 99940805 - Disclosure - Commitments and Contingencies - Minimum lease payments (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureCommitmentsAndContingenciesMinimumLeasePaymentsDetails Commitments and Contingencies - Minimum lease payments (Details) Details 47 false false R48.htm 99940901 - Disclosure - Common Stock and Stockholders' Equity - Preferred Stock (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureCommonStockAndStockholdersEquityPreferredStockDetails Common Stock and Stockholders' Equity - Preferred Stock (Details) Details 48 false false R49.htm 99940902 - Disclosure - Common Stock and Stockholders' Equity - Common Stock and At-the-Market Offering Agreement (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureCommonStockAndStockholdersEquityCommonStockAndAtMarketOfferingAgreementDetails Common Stock and Stockholders' Equity - Common Stock and At-the-Market Offering Agreement (Details) Details 49 false false R50.htm 99940903 - Disclosure - Common Stock and Stockholders' Equity - Common Stock Warrants (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureCommonStockAndStockholdersEquityCommonStockWarrantsDetails Common Stock and Stockholders' Equity - Common Stock Warrants (Details) Details 50 false false R51.htm 99941001 - Disclosure - Stock-Based Compensation - Information (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureStockBasedCompensationInformationDetails Stock-Based Compensation - Information (Details) Details 51 false false R52.htm 99941002 - Disclosure - Stock-Based Compensation - Expense (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureStockBasedCompensationExpenseDetails Stock-Based Compensation - Expense (Details) Details 52 false false R53.htm 99941003 - Disclosure - Stock-Based Compensation - Option activity (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureStockBasedCompensationOptionActivityDetails Stock-Based Compensation - Option activity (Details) Details 53 false false R54.htm 99941004 - Disclosure - Stock-Based Compensation - Option Assumptions (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureStockBasedCompensationOptionAssumptionsDetails Stock-Based Compensation - Option Assumptions (Details) Details 54 false false R55.htm 99941101 - Disclosure - Segment Information (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureSegmentInformationDetails Segment Information (Details) Details http://www.outlooktherapeutics.com/role/DisclosureSegmentInformationTables 55 false false All Reports Book All Reports otlk-20251231.xsd otlk-20251231_cal.xml otlk-20251231_def.xml otlk-20251231_lab.xml otlk-20251231_pre.xml otlk-20251231x10q.htm http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 true true